| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.2 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |